CORT has initiated the SWOG S0717 Study for treatment of metastatic renal cancer that has progressed after prior sunitinib (Sutent) or sorafenib (Nexavar) therapy. These treatments are standard firs… more →
Center for Oncology Research & Treatment--Dallas, TXJim Tucker wrote 2 months ago: URO TODAY: A trial of high doses of cancer inhibitor sunitinib on 36 elderly advanced prostate cance … more →
Sitemaster wrote 3 months ago: Today’s news reports contain items on: Racial disparities in 10-year survival, even in special … more →
Jim Tucker wrote 6 months ago: JUNE 19: URO TODAY: A new study has explored the efficacy and tolerability of sunitinib, an inhibito … more →
Sitemaster wrote 6 months ago: Articles addressed in this report deal with: The reactions of men to a diagnosis of prostate cancer … more →
bmirtsching wrote 12 months ago: CORT has initiated the SWOG S0717 Study for treatment of metastatic renal cancer that has progressed … more →
Sitemaster wrote 1 year ago: Other than the PCA3 report, additional news today includes: A new review on the combination of EBRT … more →
bmirtsching wrote 1 year ago: There have been three new drugs approved by the FDA for treatment of renal cancer between 2005 and 2 … more →
crimsoncanary wrote 1 year ago: Researchers report that the development of reversible erythrocytosis is a common side effect followi … more →
crimsoncanary wrote 1 year ago: The UK’s National Institute for Health and Clinical Excellence (NICE) has made a preliminary r … more →
crimsoncanary wrote 1 year ago: Genentech have halted its trial of Avastin in combination with Sutent following reports of several c … more →
crimsoncanary wrote 1 year ago: Sunitinib has shown efficacy in a phase II study of pancreatic neuroendocrine tumor patients. … more →
bmirtsching wrote 1 year ago: CORT has opened the Phase II Argos Therapeutics trial of RNA-loaded autologous dendritic cell (DC)im … more →
crimsoncanary wrote 1 year ago: In vitro analysis of multikinas inhibitors imatinib, sorafenib, and sunitinib in human AML cell line … more →
crimsoncanary wrote 1 year ago: Pfizer has announced that Sutent, sunitinib malate, has been approved in Japan for Gastrointestinal … more →
bmirtsching wrote 1 year ago: CORT has been chosen as an investigative site for a study of immunotherapy utilizing a primed autolo … more →
bmirtsching wrote 2 years ago: Recent studies of sunitinib (Sutent) in patients with metastatic renal cell carcinoma have demonstra … more →
bmirtsching wrote 2 years ago: After complete surgical resection of localized renal cell carcinoma, there is no existing standard p … more →
bmirtsching wrote 2 years ago: Breast cancers that do not contain growth regulator proteins for estrogen receptor (ER), progesteron … more →